A survey of prognosis for idiopathic pulmonary fibrosis who receive long term oxygen therapy.

A survey of prognosis for idiopathic pulmonary fibrosis who receive long term oxygen therapy. - A survey of prognosis for IPF who receive LTOT.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009322

Enrollment

200

Registered

2012-11-13

Start date

2012-11-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic pulmonary fibrosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IPF patients newly prescribed LTOT

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
To investigate the survival of patients with idiopathic pulmonary fibrosis (IPF) receiving long term oxygen therapy (LTOT).	—

Secondary

Measure	Time frame
To evaluate prognostic factor of patients with IPF receiving LTOT.	—

Countries

Japan

Contacts

Public ContactKensuke Kataoka

Tosei General Hospital Department of Respiratory Medicine and Allergy

kataoka@tosei.or.jp0561-82-5101

Outcome results